Resveratrol and cardiovascular diseases
D Bonnefont-Rousselot - Nutrients, 2016 - mdpi.com
The increased incidence of cardiovascular diseases (CVDs) has stimulated research for
substances that could improve cardiovascular health. Among them, resveratrol (RES), a …
substances that could improve cardiovascular health. Among them, resveratrol (RES), a …
Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease
Inflammatory bowel disease (IBD) is a chronic disorder associated with the inflammation in
the digestive tract. The exact cause of IBD is unknown; nevertheless, in IBD, the …
the digestive tract. The exact cause of IBD is unknown; nevertheless, in IBD, the …
Anti-inflammatory activity of natural stilbenoids: A review
M Dvorakova, P Landa - Pharmacological Research, 2017 - Elsevier
Resveratrol and other natural stilbenoids, including piceatannol, pterostilbene, and gnetol,
are well-known anti-inflammatory compounds with indisputable activity in vitro as well as in …
are well-known anti-inflammatory compounds with indisputable activity in vitro as well as in …
[HTML][HTML] Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases
BNM Zordoky, IM Robertson, JRB Dyck - Biochimica et Biophysica Acta …, 2015 - Elsevier
Cardiovascular disease is the leading cause of death worldwide. Despite advancements in
diagnosis and treatment of cardiovascular disease, the incidence of cardiovascular disease …
diagnosis and treatment of cardiovascular disease, the incidence of cardiovascular disease …
Polyphenols, inflammation, and cardiovascular disease
CC Tangney, HE Rasmussen - Current atherosclerosis reports, 2013 - Springer
Polyphenols are compounds found in foods such as tea, coffee, cocoa, olive oil, and red
wine and have been studied to determine if their intake may modify cardiovascular disease …
wine and have been studied to determine if their intake may modify cardiovascular disease …
Targeting mechanosensitive transcription factors in atherosclerosis
Atherosclerosis is the primary underlying cause of cardiovascular disease which
preferentially develops at arterial regions exposed to disturbed flow (DF), but much less at …
preferentially develops at arterial regions exposed to disturbed flow (DF), but much less at …
Polydatin: a review of pharmacology and pharmacokinetics
QH Du, C Peng, H Zhang - Pharmaceutical biology, 2013 - Taylor & Francis
Context: Polydatin, also named piceid (3, 4′, 5-trihydroxystilbene-3-β-d-glucoside, PD), is a
monocrystalline compound isolated from Polygonum cuspidatum Sieb. et …
monocrystalline compound isolated from Polygonum cuspidatum Sieb. et …
Targeting foam cell formation in atherosclerosis: therapeutic potential of natural products
D Wang, Y Yang, Y Lei, NT Tzvetkov, X Liu… - Pharmacological …, 2019 - ASPET
Foam cell formation and further accumulation in the subendothelial space of the vascular
wall is a hallmark of atherosclerotic lesions. Targeting foam cell formation in the …
wall is a hallmark of atherosclerotic lesions. Targeting foam cell formation in the …
Molecular mechanisms of the cardiovascular protective effects of polyphenols
R Andriantsitohaina, C Auger, T Chataigneau… - British Journal of …, 2012 - cambridge.org
Epidemiological studies have reported a greater reduction in cardiovascular risk and
metabolic disorders associated with diets rich in polyphenols. The antioxidant effects of …
metabolic disorders associated with diets rich in polyphenols. The antioxidant effects of …
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome
Alteration of nutritional habits play an essential role on the risk of developing Metabolic
Syndrome (MetS). Several epidemiological studies have shown that assuming diets rich of …
Syndrome (MetS). Several epidemiological studies have shown that assuming diets rich of …